http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007212284-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9adfd8615849e9c22cdc691df7f8b6ed |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e769aa876987cf005a92f358ec5d2e68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d58dac506c0b6d6415de80be2d40406 |
| publicationDate | 2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007212284-A |
| titleOfInvention | How to determine the prognosis of cancer patients |
| abstract | To provide a method for determining the prognosis of a cancer patient using a humoral immune response to a p53-derived peptide. The present invention relates to a method for determining the prognosis of a cancer patient, comprising the step of measuring the level of an anti-p53-derived peptide antibody in a blood sample collected from the cancer patient, wherein the antibody level is a reference value. The method is characterized in that it is highly probable that the prognosis is likely to exceed. [Selection figure] None. |
| priorityDate | 2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.